Page last updated: 2024-12-06

1h-tetrazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1H-Tetrazole is a heterocyclic aromatic compound with the formula [N4H2]. It is a colorless solid that is soluble in water and many organic solvents. It is used as a building block in the synthesis of a wide range of heterocyclic compounds, including pharmaceuticals, pesticides, and explosives. 1H-Tetrazole is also a useful ligand in coordination chemistry. The molecule can be used as a base in organic reactions, particularly in the synthesis of heterocyclic compounds. It can also be used as a catalyst in various organic reactions. 1H-Tetrazole is a useful intermediate in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. It is also an important building block in the synthesis of energetic materials, such as explosives and propellants. It is a key component in the synthesis of many other valuable organic molecules and its unique properties make it a valuable reagent for organic synthesis. 1H-Tetrazole's importance comes from its versatility and its unique properties. The molecule is a highly versatile building block, enabling the formation of a wide array of chemical compounds with diverse applications.'

tetrazole : An azaarene that is a five-membered ring composed of 4 nitrogen and 1 carbon atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2H-tetrazole : A tetrazole tautomer where the proton is located on the 2 position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67519
CHEMBL ID2148103
CHEBI ID33194
CHEBI ID33193
MeSH IDM0132454

Synonyms (50)

Synonym
AC-784
tetraazacyclopentadiene
nsc36712
1-h-tetrazole
nsc-36712
288-94-8
2h-tetrazole
CHEBI:33194
100043-29-6
CHEBI:33193 ,
tetrazole
inchi=1/ch2n4/c1-2-4-5-3-1/h1h,(h,2,3,4,5
1h-tetrazole ,
STK366101
T-2400
T-2440
AKOS003615496
d34j7pat68 ,
nsc 36712
einecs 206-023-4
unii-d34j7pat68
A819654
2h-1,2,3,4-tetrazole
T1017
27988-97-2
AKOS015955446
CHEMBL2148103
FT-0607914
FT-0607796
BP-30175
racemic tetrazole
1h-tetrazol
1h-1,2,3,4-tetrazol
1,2,3,4-tetrazole
1h-tetraazole #
DTXSID5075280
F8889-0313
1h-tetrazole, 0.45m in acetonitrile
mfcd00005247
CS-D1473
tetrazole;tetraazacyclopentadiene
BCP22123
Q58826418
Q58826308
2,3,4-triazapyrrole
288-95-9
AMY28702
1h-tetrazole (0.45m in acetonitrile)
alpha-1h-1,2,3,4-tetrazole
tetrazole solution

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" This result correlated well with an in vivo pharmacokinetics study, which showed low bioavailability of 6c in rats."( Tetrazole-based deoxyamodiaquines: synthesis, ADME/PK profiling and pharmacological evaluation as potential antimalarial agents.
Barteau, S; Chibale, K; Gut, J; Heudi, O; Kameni-Tcheudji, J; Mugumbate, GC; Njoroge, M; Rosenthal, PJ; Streckfuss, J; Tukulula, M, 2013
)
0.39
" Among substituents, a carboxyl group was identified as key for improving the oral bioavailability in cynomolgus monkeys."( The design, synthesis and evaluation of 2-aminobenzoxazole analogues as potent and orally efficacious ChemR23 inhibitors.
Imaizumi, T; Kobayashi, A; Komai, M; Maemoto, M; Otsubo, N; Otsubo, S; Takada, H, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
tetrazoleAn azaarene that is a five-membered ring composed of 4 nitrogen and 1 carbon atom.
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
tetrazoleAn azaarene that is a five-membered ring composed of 4 nitrogen and 1 carbon atom.
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID701844Dissociation constant, pKa of the compound2012Journal of medicinal chemistry, Jul-12, Volume: 55, Issue:13
Mitigating heterocycle metabolism in drug discovery.
AID687184Dissociation constant, pKa of the compound at pH 2 to 3 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (206)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (11.65)18.7374
1990's6 (2.91)18.2507
2000's41 (19.90)29.6817
2010's109 (52.91)24.3611
2020's26 (12.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.47 (24.57)
Research Supply Index5.35 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index54.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other204 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]